SARS-CoV-2 Placentitis Associated with B.1.617.2 (Delta) Variant and Fetal Distress or Demise

by Brigida, S., Clapp, M.A, Edlow, A.G, Etemad, B., Flynn, J.P, Li, J.Z, Mohammadi, A., Regan, J., Roberts, D.J, Shook, L.L, Siegel, M.R
Published 2022

Duration of viral shedding and culture positivity with postvaccination SARSCoV-2 delta variant infections

by Barczak, A.K, Boucau, J., Chamberlin, G.C, Choudhary, M.C, Flynn, J.P, Gilbert, R.F, Goldstein, R.H, Haneuse, S., Iyer, S., Lemieux, J.E, Li, J.Z, Luu, J., North, C.M, Regan, J., Reynolds, Z., Sacks, C.A, Siedner, M.J, Uddin, R., Vyas, J.M, Vyas, T.
Published 2022

Health system impacts of SARS-CoV − 2 variants of concern: a rapid review

by Boulos, L., Crowther, D., Curran, J.A, Dol, J., Doroshenko, A., Gallant, A., Hastings, S., Macdonald, M., Martin-Misener, R., McCulloch, H., Reynolds, B., Saxinger, L., Shin, H.D, Somerville, M., Tricco, A.C, Wong, H.
Published 2022

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

by Afran, L., Ayres, F., Chaponda, M., Chibwana, M.G, Gordon, S.B, Hermanaus, T., Heyderman, R.S, Jambo, K.C, Jassi, C., Jere, K., Kamng’ona, R., Kwatra, G., Madhi, S., Mandolo, J., Mitole, N., Moore, P.L, Motlou, T., Moyo-Gwete, T., Mwandumba, H.C, Mwenechanya, P., Mzindle, N., Mzinza, D., Tembo, G.
Published 2022